Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacophore Model To Discover OX1 and OX2 Orexin Receptor Ligands
Ainoleena Turku, Alexandre Borrel, Teppo O. Leino, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 18, pp. 8263-8275
Closed Access | Times Cited: 19

Showing 19 citing articles:

Synthesis and characterization of multicyclic oxadiazoles and 1-hydroxytetrazoles as energetic materials
Philip F. Pagoria, Mao‐Xi Zhang, Nathaniel B. Zuckerman, et al.
Chemistry of Heterocyclic Compounds (2017) Vol. 53, Iss. 6-7, pp. 760-778
Closed Access | Times Cited: 72
Orexin Signaling: A Complex, Multifaceted Process
Natasha C. Dale, Daniël Hoyer, Laura H. Jacobson, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 26
Orexin supplementation in narcolepsy treatment: A review
Eugenie Nepovimová, Jana Janočková, Jan Misík, et al.
Medicinal Research Reviews (2018) Vol. 39, Iss. 3, pp. 961-975
Closed Access | Times Cited: 41
Chronopathophysiological implications of orexin in sleep disturbances and lifestyle-related disorders
Hiroshi Tsuneki, Tsutomu Wada, Toshiyasu Sasaoka
Pharmacology & Therapeutics (2017) Vol. 186, pp. 25-44
Closed Access | Times Cited: 28
Orexin receptor agonist Yan 7874 is a weak agonist of orexin/hypocretin receptors and shows orexin receptor-independent cytotoxicity
Ainoleena Turku, Maiju K. Rinne, Gustav Boije af Gennäs, et al.
PLoS ONE (2017) Vol. 12, Iss. 6, pp. e0178526-e0178526
Open Access | Times Cited: 22
Azulene-based compounds for targeting orexin receptors
Teppo O. Leino, Ainoleena Turku, Jari Yli‐Kauhaluoma, et al.
European Journal of Medicinal Chemistry (2018) Vol. 157, pp. 88-100
Closed Access | Times Cited: 21
Orexin research: patent news from 2016
Christoph Boss, Catherine Roch
Expert Opinion on Therapeutic Patents (2017) Vol. 27, Iss. 10, pp. 1123-1133
Closed Access | Times Cited: 17
Cartography of rhodopsin-like G protein-coupled receptors across vertebrate genomes
Maiju K. Rinne, Ziaurrehman Tanoli, Asifullah Khan, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 14
Pharmacological characterization of the orexin/hypocretin receptor agonist Nag 26
Maiju K. Rinne, Teppo O. Leino, Ainoleena Turku, et al.
European Journal of Pharmacology (2018) Vol. 837, pp. 137-144
Closed Access | Times Cited: 14
Determinants of Orexin Receptor Binding and Activation—A Molecular Dynamics Study
Lasse Karhu, Aniket Magarkar, Alex Bunker, et al.
The Journal of Physical Chemistry B (2019) Vol. 123, Iss. 12, pp. 2609-2622
Open Access | Times Cited: 11
Computer‑aided design of temozolomide derivatives based on alkylglycerone phosphate synthase structure with isothiocyanate and their pharmacokinetic/toxicity prediction and anti‑tumor activity in vitro
Bing Yang, Xiaobo Li, Lu He, et al.
Biomedical Reports (2018)
Open Access | Times Cited: 10
Mitoxantrone, pixantrone and mitoxantrone (2-hydroxyethyl)piperazine are toll-like receptor 4 antagonists, inhibit NF-κB activation, and decrease TNF-alpha secretion in primary microglia
Maiju K. Rinne, Kert Mätlik, Tiina J. Ahonen, et al.
European Journal of Pharmaceutical Sciences (2020) Vol. 154, pp. 105493-105493
Open Access | Times Cited: 9
Understanding sleep-wake mechanisms and drug discovery
Ana Clementina Equihua-Benítez, Khalil Guzmán-Vásquez, René Drucker-Colı́n
Expert Opinion on Drug Discovery (2017) Vol. 12, Iss. 7, pp. 643-657
Closed Access | Times Cited: 9
Stapled truncated orexin peptides as orexin receptor agonists
Lasse Karhu, Janne Weisell, Pauli M. Turunen, et al.
Peptides (2018) Vol. 102, pp. 54-60
Open Access | Times Cited: 9
Structure–Activity Relationships of 1‐Benzoylazulenes at the OX1 and OX2 Orexin Receptors
Ainoleena Turku, Teppo O. Leino, Lasse Karhu, et al.
ChemMedChem (2019) Vol. 14, Iss. 9, pp. 965-981
Closed Access | Times Cited: 9
Investigation of New Orexin 2 Receptor Modulators Using In Silico and In Vitro Methods
Jana Janočková, Rafael Doležal, Eugenie Nepovimová, et al.
Molecules (2018) Vol. 23, Iss. 11, pp. 2926-2926
Open Access | Times Cited: 8
Allosteric interactions via the orthosteric ligand binding sites in a constitutive G-protein-coupled receptor homodimer
Jyrki P. Kukkonen
Pharmacological Research (2020) Vol. 166, pp. 105116-105116
Closed Access | Times Cited: 2
Orexins
Safoor Fathima, Sireesha Murala, Pradeep C. Bollu
Springer eBooks (2022), pp. 181-209
Closed Access | Times Cited: 1
Pharmacology of Orexin/Hypocretin Receptors
Jyrki P. Kukkonen
Elsevier eBooks (2019), pp. 31-68
Closed Access
Page 1

Scroll to top